Effect of LSD on prepulse inhibition and spontaneous behavior in the rat: A pharmacological analysis and comparison between two rat strains

Neuropsychopharmacology

Volumn 25, Issue 4, 2001, Pages 565-575

  Ouagazzal, A M ^a,b   Grottick, A J ^a   Moreau, J L ^a   Higgins, G A ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

5 HT2 receptor; Hallucinogen; LSD; PPI

Indexed keywords

4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIDINYL]BENZENESULFONAMIDE; 4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIMIDINYL]BENZENESULFONAMIDE; 4,5,7A,8,9,10,11,11A OCTAHYDRO 10 METHYL 7H INDOLO[1,7 BC][2,6]NAPHTHYRIDINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; HALOPERIDOL; LYSERGIDE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 6 RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BACK MUSCLE; CONTROLLED STUDY; FOREFOOT; HYPERACTIVITY; LOCOMOTION; MALE; MUSCLE CONTRACTION; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RUG EFFECT; STRAIN DIFFERENCE; WET DOG SHAKES;

ANIMALS; BEHAVIOR, ANIMAL; DOPAMINE ANTAGONISTS; HALLUCINOGENS; LYSERGIC ACID DIETHYLAMIDE; MALE; MOTOR ACTIVITY; MUSCLE CONTRACTION; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D2; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SPECIES SPECIFICITY; STARTLE REACTION;

EID: 0034851527     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00282-2     Document Type: Article

References (53)

1. LSD-induced alteration of locomotor patterns and exploration in rats
2. Serotonin and hallucinogens
3. Serotonin model of schizophrenia: Emerging role of glutamate mechanisms
4. A review of central 5-HT receptors and their function
5. 6 receptor antagonist, Ro 04-6790, in rats
6. 6 receptor stably expressed in HEK293 cells
7. 2C receptor antagonist
8. The dopamine receptor: Differential binding of d-LSD and related agents to agonist and antagonist states
9. 2C receptors
10. 2C receptors in the stimulus effects of hallucinogenic drugs I: Antagonist correlation analysis
11. Characterization of the 5-HT receptor suptypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats
12. 1A receptor antagonist, WAY-100635
13. Behavioral studies of hallucinogenic drugs in animals: Implications for schizophrenia research
14. 5A receptor
15. 2C receptors on cocaine- and food-maintained behavior
16. 2 agonist Ro 60-0175 and the indirect 5-HT agonist dexfenfluramine
17. 2 agonist DOI: Effects of MDL 100,907, clozapine, risperidone and haloperidol
18. 2A antagonist with a favorable CNS safety profile
19. 2C receptor antagonist
20. Rat strain differences in the ability to disrupt sensorimotor gating are limited to dopaminergic system, specific to prepulse inhibition, and related to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity
21. 2C receptors
22. Dopaminergic stimulation disrupts sensorimotor gating in the rat
23. 2C receptor agonists: Pharmacological characteristics and therapeutic potential
24. 2C receptors mediate penile erections in rats: Actions of novel and selective agonists and antagonists
25. Diissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol
26. 2C receptor subtypes in the two types of fear generated by the elevated T-maze
27. 2A antagonist
28. 2C receptors
29. 2A receptor affinity
30. 2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats
31. 3 mediated control of dopaminergic function
32. 5 receptor reveals a remarkable heterogeneity within the 5HT1D receptor family
33. 2C receptors in CHO-K1 cells
34. Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenylaminopropane)-2 (DOI)
35. 4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice
36. Differential effects of apomorphine on prepulse inhibition of acoustic startle reflex in two rats strains
37. Prepulse inhibition as screening test for potential antipsychotics
38. 5-Hydroxytryptamine 1a-receptor agonists block prepulse inhibition of acoustic startle reflex
39. 2A receptor in atypical antipsychotic drug actions
40. 2C antagonistic properties of newer antipsychotics
41. Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the atypical antipsychotics, clozapine and risperidone
42. Molecular cloning and expression of 5-hydroxytryptamine7 serotonin receptor subtype
43. Multiple serotonin receptor subtypes modulate prepulse inhibition of startle response in rats
44. 2C receptors
45. 2A receptors in the ventral pallidum
46. 6 receptors
47. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia
48. Discrepant findings of clozapine effects on prepulse inhibition of startle: Is it the route or the rat?
49. 2 receptors as a site of action for LSD and phenylisopropylamine hallucinogens
50. Differences between three rat strains in sensitivity to prepulse inhibition of an acoustic startle response: Influence of apomorphine and phencyclidine pretreatment
51. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as model to screen antipsychotic drugs
52. 2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats
53. Selectivity of action of typical and atypical antipsychotic drugs as antagonists of the behavioral effects of 1-[2,5-dimethoxy-4-iodophenyl]2-aminopropane (DOI)